Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    savita thakur thakur
    savita thakur thakur
      • Home
      • savita thakur thakur

      Articles By : savita thakur thakur

      Almirall and Sun Pharma enter into a License Agreement for Tildrakizumab in Europe for Psoriasis

      Almirall and Sun Pharma enter into a License Agreement for Tildrakizumab in Europe for Psoriasis

      savita thakur thakur29 July 2016 1:38 PM IST
      Mumbai : Sun Pharma, , and its wholly owned subsidiary and Almirall have recently announced a licensing agreement on the development and...
      FDA approves Adlyxin to treat type 2 diabetes

      FDA approves Adlyxin to treat type 2 diabetes

      savita thakur thakur29 July 2016 1:37 PM IST
      The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along...
      AstraZeneca earnings hit by waning cholesterol drug sales

      AstraZeneca earnings hit by waning cholesterol drug sales

      savita thakur thakur29 July 2016 1:37 PM IST
      London : Generic competition to cholesterol buster Crestor in the U.S. market pushed second quarter earnings down by nearly a third at drugmaker...
      FDA updates warnings for fluoroquinolone antibiotics

      FDA updates warnings for fluoroquinolone antibiotics

      savita thakur thakur28 July 2016 12:45 PM IST
      The U.S. Food and Drug Administration approved safety labeling changes for a class of antibiotics, called fluoroquinolones, to enhance warnings about...
      Ziqitzas emergency medical service unit to make a foray into Dubai

      Ziqitza's emergency medical service unit to make a foray into Dubai

      savita thakur thakur28 July 2016 12:44 PM IST
      Mumbai : Ziqitza Gulf Medical Response and Ambulance Services (GMRAS), a subsidiary of Ziqitza Healthcare Ltd recently won a tender to service the...
      GlaxoSmithKline invests $360 million in post Brexit UK manufacturing

      GlaxoSmithKline invests $360 million in post Brexit UK manufacturing

      savita thakur thakur28 July 2016 12:44 PM IST
      London : Drugmaker GlaxoSmithKline revealed plans to invest £275 million into three of its British manufacturing sites, shrugging off Brexit...
      RPG Life Sciences inks pact to acquire Sun Pharmas 7 brands

      RPG Life Sciences inks pact to acquire Sun Pharma's 7 brands

      savita thakur thakur28 July 2016 12:43 PM IST
      New Delhi : Drug firm RPG Life Sciences inked a pact to acquire seven prescription brands from Sun Pharmaceutical Industries for a consideration of Rs...
      Lupin gets USFDA tentative nod for generic Lexiva tablets

      Lupin gets USFDA tentative nod for generic Lexiva tablets

      savita thakur thakur28 July 2016 12:43 PM IST
      Drug firm Lupin has received tentative approval from the US health regulator to market generic Lexiva tablets used for treatment of HIV infection in...
      Columbia Asia Receives $101M ( Rs 680 cr Appx) Investment from Mitsui & Co.

      Columbia Asia Receives $101M ( Rs 680 cr Appx) Investment from Mitsui & Co.

      savita thakur thakur27 July 2016 8:09 PM IST
      Columbia Asia, one of the largest and healthcare companies in Asia, announced today it is receiving $101 million in investment from Mitsui & Co.,...
      Many prohibited drugs available in markets: Minister Ananth Kumar

      Many prohibited drugs available in markets: Minister Ananth Kumar

      savita thakur thakur27 July 2016 2:57 PM IST
      New Delhi : As many as 439 drugs, including brands like Phensedyl and Corex which have been banned for sale and distribution, but some of them...
      Recro Pharmas intravenous painkiller succeeds in trial, shares soar

      Recro Pharma's intravenous painkiller succeeds in trial, shares soar

      savita thakur thakur27 July 2016 2:54 PM IST
      Recro Pharma Inc (REPH.O) said an intravenous version of its lead painkiller was successful in the first of two pivotal late-stage trials, sending the...
      Dr Reddy

      Dr Reddy's net plunges 76 per cent in Q1

      savita thakur thakur27 July 2016 2:52 PM IST
      Hyderabad : Pharma major Dr Reddy's Laboratories Ltd reported 76 per cent decline in consolidated net profit for the first quarter of 2016-17, at Rs...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok